Search

Joseph E Palys

Examiner (ID: 1283)

Most Active Art Unit
2413
Art Unit(s)
2413, 2787, 2313, 2899, 2785
Total Applications
453
Issued Applications
351
Pending Applications
23
Abandoned Applications
79

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3873501 [patent_doc_number] => 05728387 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Structural gene of pneumococcal protein' [patent_app_type] => 1 [patent_app_number] => 8/214164 [patent_app_country] => US [patent_app_date] => 1994-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 4 [patent_no_of_words] => 4111 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728387.pdf [firstpage_image] =>[orig_patent_app_number] => 214164 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/214164
Structural gene of pneumococcal protein Mar 16, 1994 Issued
Array ( [id] => 4045290 [patent_doc_number] => 05874533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'HIV-2 envelope polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/213416 [patent_app_country] => US [patent_app_date] => 1994-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 9932 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874533.pdf [firstpage_image] =>[orig_patent_app_number] => 213416 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/213416
HIV-2 envelope polypeptides Mar 14, 1994 Issued
08/213200 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING ALPHA-GALACTOSYL EPITOPES Mar 14, 1994 Abandoned
08/207910 METHOD FOR ENHANCING THE ASSOCIATION OF EXOGENOUS PEPTIDES WITH CLASS I MHC MOLECULES ON THE SURFACE OF ANTIGEN PRESENTING CELLS WITH B-2 MICROGLOBULIN Mar 6, 1994 Abandoned
Array ( [id] => 3717560 [patent_doc_number] => 05616688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)' [patent_app_type] => 1 [patent_app_number] => 8/207888 [patent_app_country] => US [patent_app_date] => 1994-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 15906 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616688.pdf [firstpage_image] =>[orig_patent_app_number] => 207888 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/207888
Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) Mar 6, 1994 Issued
08/200744 THERAPEUTIC PREVENTIVE VACCINES FOR HIV Feb 22, 1994 Abandoned
Array ( [id] => 3700171 [patent_doc_number] => 05674705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Productive of human T-cell leukemia (lymphotropic) retrovirus (HTLV-1) envelope protein fragments in bacteria and use in seroepidemiological studies' [patent_app_type] => 1 [patent_app_number] => 8/194818 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2200 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674705.pdf [firstpage_image] =>[orig_patent_app_number] => 194818 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/194818
Productive of human T-cell leukemia (lymphotropic) retrovirus (HTLV-1) envelope protein fragments in bacteria and use in seroepidemiological studies Feb 13, 1994 Issued
Array ( [id] => 3612556 [patent_doc_number] => 05510238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein fragments in bacteria and use in seroepidemiological studies' [patent_app_type] => 1 [patent_app_number] => 8/193510 [patent_app_country] => US [patent_app_date] => 1994-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2127 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510238.pdf [firstpage_image] =>[orig_patent_app_number] => 193510 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/193510
Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein fragments in bacteria and use in seroepidemiological studies Feb 6, 1994 Issued
Array ( [id] => 3759046 [patent_doc_number] => 05851813 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Primate lentivirus antigenic compositions' [patent_app_type] => 1 [patent_app_number] => 8/188583 [patent_app_country] => US [patent_app_date] => 1994-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 67 [patent_no_of_words] => 18729 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851813.pdf [firstpage_image] =>[orig_patent_app_number] => 188583 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/188583
Primate lentivirus antigenic compositions Jan 26, 1994 Issued
Array ( [id] => 3690990 [patent_doc_number] => 05660828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Method of treating autoimmune and/or viral-induced diseases that are mediated by CD8 phenotype T cells' [patent_app_type] => 1 [patent_app_number] => 8/177806 [patent_app_country] => US [patent_app_date] => 1994-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4356 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/660/05660828.pdf [firstpage_image] =>[orig_patent_app_number] => 177806 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/177806
Method of treating autoimmune and/or viral-induced diseases that are mediated by CD8 phenotype T cells Jan 5, 1994 Issued
08/178461 METHOD OF TREATING OR PREVENTING AUTOIMMUNE UVERORETINITIS IN MAMMALS Jan 5, 1994 Abandoned
Array ( [id] => 3700415 [patent_doc_number] => 05674720 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Design and construction of non-infectious human retroviral mutants deficient in genomic RNA' [patent_app_type] => 1 [patent_app_number] => 8/176682 [patent_app_country] => US [patent_app_date] => 1994-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8780 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674720.pdf [firstpage_image] =>[orig_patent_app_number] => 176682 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/176682
Design and construction of non-infectious human retroviral mutants deficient in genomic RNA Jan 2, 1994 Issued
08/171858 VACCINES BASED ON MEMBRANE BOUND PROTEINS AND PROCESS FOR MAKING THEM Dec 20, 1993 Abandoned
Array ( [id] => 3660260 [patent_doc_number] => 05591823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Expression of specific immunogens using viral antigens' [patent_app_type] => 1 [patent_app_number] => 8/169813 [patent_app_country] => US [patent_app_date] => 1993-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8817 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591823.pdf [firstpage_image] =>[orig_patent_app_number] => 169813 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/169813
Expression of specific immunogens using viral antigens Dec 16, 1993 Issued
Array ( [id] => 3690701 [patent_doc_number] => 05691448 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome' [patent_app_type] => 1 [patent_app_number] => 8/161290 [patent_app_country] => US [patent_app_date] => 1993-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15667 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691448.pdf [firstpage_image] =>[orig_patent_app_number] => 161290 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/161290
Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome Dec 1, 1993 Issued
Array ( [id] => 3720265 [patent_doc_number] => 05681556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Method and compositions for suppressing allograft rejection in mammals' [patent_app_type] => 1 [patent_app_number] => 8/159044 [patent_app_country] => US [patent_app_date] => 1993-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7134 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681556.pdf [firstpage_image] =>[orig_patent_app_number] => 159044 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/159044
Method and compositions for suppressing allograft rejection in mammals Nov 28, 1993 Issued
Array ( [id] => 3623074 [patent_doc_number] => 05688914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus' [patent_app_type] => 1 [patent_app_number] => 8/150249 [patent_app_country] => US [patent_app_date] => 1993-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8156 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688914.pdf [firstpage_image] =>[orig_patent_app_number] => 150249 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/150249
Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus Nov 8, 1993 Issued
08/145664 INDUCTION OF PROTECTION AGAINST VIRAL INFECTION BY SYNERGY BETWEEN VIRUS ENVELOPE GLYCOPROTEIN AND PEPTIDES CORRESPONDING TO NEUTRALIZATION EPITOPES OF THE GLYCOPROTEIN Nov 3, 1993 Abandoned
08/143577 INHIBITION OF HIV MUCOSAL BINDING Oct 25, 1993 Abandoned
Array ( [id] => 3993480 [patent_doc_number] => 05858366 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding' [patent_app_type] => 1 [patent_app_number] => 8/135312 [patent_app_country] => US [patent_app_date] => 1993-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11858 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858366.pdf [firstpage_image] =>[orig_patent_app_number] => 135312 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/135312
Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding Oct 11, 1993 Issued
Menu